← AXT overview

AXT vs Teradyne: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

AXT Inc (AXTI)

Q3 2026
▲3▼1

AXT Soars on AI InP Demand, Record Prices, Big Capital Raise

  • AI-driven indium phosphide demand Q2 revenue jumped 160% to $47.6M, gross margin hit 44.9%, and backlog exceeded $100M as AI data centers drove demand for indium phosphide used in high-speed optical connections.

    This is the core fundamental driver of the stock's surge this period.

  • Record price hikes and supply deals Record InP price increases above 10% lifted shares, while supply deals with Casela, Coherent, and Lumentum—including prepayments through 2031—locked in revenue and reduced export and payment risks.

    Pricing power and long-term contracts directly boosted investor confidence and revenue visibility.

  • Massive capital raise for capacity expansion AXT raised $632M, ending with $748.8M cash to double InP capacity in 2026 and expand again in 2027, positioning for co-packaged optics from late 2027.

    The capital raise funds growth and signals confidence in future demand.

  • Competition and uncertain future revenue Rising competition from Coherent and Lumentum remains a risk, and future co-packaged optics revenue is still uncertain and years away.

    This is the main counterweight to the positive drivers.

August 2026
▲4

AXT's AI-Driven InP Boom: Record Results, Price Hikes, Supply Deals

  • Blowout Q2 Earnings AXT reported Q2 revenue up 160% to $47.6 million and gross margin expanding to 44.9% from 8%, driven by record indium phosphide sales for AI data centers. This profit surge directly boosts investor confidence and the stock price.

    It's the core fundamental catalyst that kicked off the period's rally.

  • Record InP Price Hikes A report of Q4 indium phosphide substrate price increases exceeding 10%—the largest on record—sent AXT shares up 13.7% in a day. Higher prices mean more revenue and profit per wafer, directly lifting AXT's earnings potential.

    It's a new pricing catalyst that directly boosts AXT's core product economics.

  • Expanded Supply Agreements AXT signed long-term InP supply deals with Casela, Coherent, and Lumentum, including prepayments and commitments through 2031. With demand already exceeding capacity, these contracts lock in future revenue and improve visibility, supporting the stock.

    It shows concrete customer commitments that de-risk future growth.

  • Strong Liquidity for Expansion AXT ended Q2 with $748.8 million in cash after a $632 million offering, funding a doubling of InP capacity in 2026 and another expansion in 2027. This financial strength lets AXT meet soaring AI demand, but rising competition from Coherent and Lumentum is a risk.

    It explains how AXT can scale to capture demand, while noting a real counterweight.

Latest
▲4

AXT's AI-Driven InP Boom: Record Results, Price Hikes, Supply Deals

  • Blowout Q2 Earnings AXT reported Q2 revenue up 160% to $47.6 million and gross margin expanding to 44.9% from 8%, driven by record indium phosphide sales for AI data centers. This profit surge directly boosts investor confidence and the stock price.

    It's the core fundamental catalyst that kicked off the period's rally.

  • Record InP Price Hikes A report of Q4 indium phosphide substrate price increases exceeding 10%—the largest on record—sent AXT shares up 13.7% in a day. Higher prices mean more revenue and profit per wafer, directly lifting AXT's earnings potential.

    It's a new pricing catalyst that directly boosts AXT's core product economics.

  • Expanded Supply Agreements AXT signed long-term InP supply deals with Casela, Coherent, and Lumentum, including prepayments and commitments through 2031. With demand already exceeding capacity, these contracts lock in future revenue and improve visibility, supporting the stock.

    It shows concrete customer commitments that de-risk future growth.

  • Strong Liquidity for Expansion AXT ended Q2 with $748.8 million in cash after a $632 million offering, funding a doubling of InP capacity in 2026 and another expansion in 2027. This financial strength lets AXT meet soaring AI demand, but rising competition from Coherent and Lumentum is a risk.

    It explains how AXT can scale to capture demand, while noting a real counterweight.

July 2026
▲4

AXT's AI-Driven Indium Phosphide Demand Surges with New Supply Deals

  • Record Indium Phosphide Revenue and Backlog AXT expects record second-quarter Indium Phosphide revenue, driven by AI data center demand. The company has already secured about $34 million in Q2 revenue and has a backlog exceeding $100 million, the highest ever. This strong demand pushes the stock up as investors see accelerating growth.

    This point directly explains the surge in demand for AXT's core product, a key driver of the stock's recent rise.

  • New Supply Agreements Reduce Risk and Lock in Revenue AXT signed a $25.4 million supply deal with China's Casela for 2027 and a three-year agreement with Coherent, including a $22.3 million prepayment. These deals limit export and payment risks and provide revenue visibility, boosting investor confidence and the stock price.

    These agreements are new, material contracts that de-risk future revenue and support the bullish case for AXTI.

  • Expansion into Co-Packaged Optics for Future Growth AXT is positioning for co-packaged optics, a next-generation AI data center technology, with commercial opportunities expected from late 2027. This potential new revenue stream, alongside capacity expansion, gives investors a longer-term growth narrative that supports the stock.

    This highlights a new growth avenue that could drive future demand, relevant to the big picture of why AXTI is moving.

  • Analyst Upgrade and Board Appointment Northland reiterated an Outperform rating and raised its price target to $125, citing a positive conference appearance. AXT also appointed a new board member with strong financial experience. These developments reinforce positive sentiment and support the stock's upward momentum.

    Analyst actions and governance improvements can influence investor perception and are part of the current positive narrative.

▲4

AXT's AI-Driven Indium Phosphide Demand Surges with New Supply Deals

  • Record Indium Phosphide Revenue and Backlog AXT expects record second-quarter Indium Phosphide revenue, driven by AI data center demand. The company has already secured about $34 million in Q2 revenue and has a backlog exceeding $100 million, the highest ever. This strong demand pushes the stock up as investors see accelerating growth.

    This point directly explains the surge in demand for AXT's core product, a key driver of the stock's recent rise.

  • New Supply Agreements Reduce Risk and Lock in Revenue AXT signed a $25.4 million supply deal with China's Casela for 2027 and a three-year agreement with Coherent, including a $22.3 million prepayment. These deals limit export and payment risks and provide revenue visibility, boosting investor confidence and the stock price.

    These agreements are new, material contracts that de-risk future revenue and support the bullish case for AXTI.

  • Expansion into Co-Packaged Optics for Future Growth AXT is positioning for co-packaged optics, a next-generation AI data center technology, with commercial opportunities expected from late 2027. This potential new revenue stream, alongside capacity expansion, gives investors a longer-term growth narrative that supports the stock.

    This highlights a new growth avenue that could drive future demand, relevant to the big picture of why AXTI is moving.

  • Analyst Upgrade and Board Appointment Northland reiterated an Outperform rating and raised its price target to $125, citing a positive conference appearance. AXT also appointed a new board member with strong financial experience. These developments reinforce positive sentiment and support the stock's upward momentum.

    Analyst actions and governance improvements can influence investor perception and are part of the current positive narrative.

Teradyne Inc (TER)

Q3 2026
▲2▼2

AI test demand booms, but sentiment swings sharply

  • AI-driven revenue surge Q2 revenue more than doubled to $1.33 billion, with AI-related sales over 60% and record memory test revenue of $212 million, showing booming demand for Teradyne's chip-testing equipment.

    This is the core positive driver of the quarter, directly tied to Teradyne's financial performance.

  • Analyst upgrades and new products Guidance beat expectations, analysts raised price targets as high as $550, and new products like the Iris 100 and Magnum E2 support future growth, boosting investor confidence.

    This reflects positive sentiment and product innovation that can drive the stock higher.

  • TSMC capex sparks margin worries TSMC's raised capital spending plan triggered concerns about Teradyne's profit margins, leading to a 5.1% selloff as investors feared pricing pressure or higher costs.

    This is a key negative event that caused a notable stock drop during the quarter.

  • AI safety warnings and Citi caution AI safety warnings and Citigroup's caution on AI spending triggered an 11.7% single-day drop, highlighting Teradyne's vulnerability to any slowdown in AI investment or negative sentiment.

    This captures the sharp negative sentiment swing and the stock's dependence on AI infrastructure spending.

August 2026
▲2▼2

AI Test Demand Booms, But AI Sentiment Fears Hit Teradyne

  • Record AI-Driven Chip-Test Demand Teradyne's Q2 revenue more than doubled to $1.33 billion, with AI-related sales over 60% of the total. Memory test revenue hit a record $212 million, showing strong demand for chip-testing equipment.

    This is the core positive driver of Teradyne's business performance during the period.

  • New Products and Analyst Optimism New products like the Iris 100 optical tester, Magnum E2 memory tester, and Universal Robots' Gen 7 platform position Teradyne for growth. Susquehanna raised its price target to $550, reflecting bullish sentiment.

    Highlights product innovation and analyst confidence as positive factors for future growth.

  • AI Sentiment Fears Trigger Sharp Selloff Safety warnings from Anthropic, OpenAI, and SpaceX leaders, plus a Citigroup caution on AI spending, caused an 11.7% single-day drop. Teradyne's stock is highly sensitive to AI sentiment swings.

    This is the main negative driver, showing how external AI concerns can sharply impact Teradyne's stock.

  • Dependence on Continued AI Infrastructure Buildout Teradyne's fortunes depend heavily on rapid AI infrastructure spending. Any slowdown in AI buildout poses a serious risk to demand for its test equipment and future growth.

    This risk factor is crucial for understanding Teradyne's vulnerability to AI spending trends.

Latest
▲4

AI Test Demand Drives Record Results and New Products

  • Record AI-Driven Revenue Growth Teradyne's Q2 revenue hit $1.33 billion, up 104% year-over-year, with AI-related sales exceeding 60% of total. This massive growth directly boosts profits and shows the AI boom is still fueling demand for Teradyne's chip-testing equipment.

    This is the core reason TER is moving: explosive AI-driven sales growth.

  • New Products Expand AI and Memory Test Leadership Teradyne launched the Iris 100 optical test platform and Magnum E2 memory tester, targeting AI data-center interconnects and advanced memory chips. These innovations open new revenue streams and keep Teradyne ahead in the fast-growing AI test market.

    New products are a key driver of future growth and competitive positioning.

  • Memory Test Revenue Hits Record High Memory revenues reached a record $212 million in Q2, the third straight quarter above $200 million, with book-to-bill above 2. Management expects the memory test market to grow over 40% in 2026, signaling strong ongoing demand.

    Memory is a significant and growing part of Teradyne's business, directly impacting revenue.

  • Analyst Upgrades and Positive Sentiment Susquehanna raised its price target to $550, citing strong backlog and wafer fab equipment spending. Teradyne also jumped 8% on upbeat AI data-center and HDD supply commentary, reflecting growing investor confidence.

    Analyst actions and market sentiment directly influence TER's stock price.

▲2▼1

AI test demand keeps Teradyne booming, but safety warnings spark a sharp pullback

  • AI demand drives blowout test results Teradyne's chip-testing sales more than doubled from a year ago, with over 60% of revenue tied to AI data centers. New UltraFLEXplus instruments keep that momentum going, so rising AI spending directly lifts Teradyne's sales and profits.

    This is the core new fundamental driver of Teradyne's business and stock.

  • Robotics gets a new growth platform Universal Robots launched its Gen 7 platform with faster controllers and new arms, aiming at industrial AI. Robotics revenue already rose 33% to $100 million, and Goldman's big humanoid-robot forecast suggests this segment could become a larger future driver.

    It shows a second, newer growth engine beyond chip testing.

  • AI safety warnings trigger sharp selloff Anthropic, OpenAI and SpaceX leaders called for slowing frontier AI, and Citigroup warned AI spending could cool. Teradyne fell 11.7% in a day because its sales depend on continued rapid AI infrastructure buildout. This is a real risk to the story.

    It is the main new counterweight and explains the recent price drop.

July 2026
▲3▼1

Teradyne hits record on AI test demand, but TSMC cost fears bite

  • Record Q2 results and strong guidance Teradyne reported record quarterly results: revenue more than doubled from a year earlier, earnings beat expectations, and AI-related sales made up about 70% of the total. Its outlook for the next quarter also came in well above what analysts expected.

    This is the core new fundamental event that drove the stock in July.

  • Analyst upgrades and rising fair value estimates After the results, analysts raised their price targets, with some as high as $550, pointing to strong chip-testing demand, a backlog stretching beyond a year, and robotics exposure through Universal Robots. Fair value estimates also climbed on AI infrastructure spending.

    Shows how professional investors re-rated the stock upward during the period.

  • TSMC capex plan sparks margin worries TSMC's raised 2026 spending plan ($60–64 billion) triggered a 5.1% selloff in Teradyne shares. Investors worried that higher costs from overseas expansion and new 2-nanometer chip production could squeeze profits across the chip supply chain, including test equipment makers.

    This is the main new counterweight that pulled the stock down during the month.

  • China Nvidia H200 imports and cooler inflation Two outside forces helped tech stocks: China may allow imports of Nvidia's H200 chips, which would support demand for advanced chip testing, and cooler inflation data lifted rate-sensitive technology shares by easing fears of further interest-rate hikes.

    These macro and policy shifts provided a supportive backdrop for Teradyne's shares.

▲3

Teradyne's Record Q2 and Strong Q3 Guidance Confirm AI-Driven Demand

  • Record Q2 Revenue and Earnings Beat Teradyne reported Q2 revenue of $1.33 billion, up 104% year-over-year, and adjusted EPS of $2.47, beating estimates. This shows the company is selling much more test equipment as AI chips get more complex, directly boosting profits and the stock price.

    This is the core new event that drove the stock up 14% after hours and 9% the next day.

  • Q3 Guidance Above Estimates on Strong Chip Equipment Demand Teradyne guided Q3 revenue to $1.20-$1.30 billion, well above the $1.04 billion consensus, and adjusted EPS to $1.85-$2.15, above the $1.53 estimate. This signals that demand for chip-testing equipment remains strong, which lifts investor confidence and pushes the stock higher.

    The guidance beat is a key new driver that reassured investors about future growth.

  • AI-Driven Orders Remain Very Strong Carillon Eagle Mid Cap Growth Fund highlighted Teradyne's very strong orders driven by AI-related demand for memory and custom silicon chips. This confirms that the AI boom continues to fuel demand for Teradyne's testing equipment, supporting the stock's long-term growth story.

    This provides third-party validation of sustained AI-driven demand, reinforcing the positive outlook.

▲3▼1

AI Demand and Rate Hopes Lift Teradyne Despite Capex Cost Fears

  • BofA raises target to $525 on bigger chip market BofA lifted its Teradyne price target to $525 from $365, saying the total chip market will be much bigger by 2030, driven by memory and data centers. Higher targets pull the stock up because they signal analysts expect more future profit.

    This is a new analyst action that directly raises expectations for Teradyne's value.

  • China may allow Nvidia H200 imports, boosting test demand Reports that China may let tech firms buy limited Nvidia H200 AI chips sent chip stocks higher, with Teradyne up 5.9%. More AI chip production means more demand for Teradyne's testing equipment, pushing the stock up.

    This is a new geopolitical development that could open a large market for AI chips and test gear.

  • Cooler inflation and IBM AI spending lift chip stocks A softer June inflation report lowered the expected path for interest rates, which helps high-priced tech stocks. IBM's warning that clients are spending heavily on AI servers confirmed strong demand, sending Teradyne up 3.6%.

    This new macro and demand signal directly boosted Teradyne and the whole chip sector.

  • TSMC capex reset triggers selloff on margin worries TSMC raised its 2026 spending plan to $60–$64 billion but warned that overseas expansion and new 2nm chip costs will squeeze profit margins. That shifted investor focus to cost pressures, and Teradyne fell 5.1% as part of a broad chip selloff.

    This is a new negative event that shows a real counterweight to the AI optimism.

▲4

AI Test Demand Drives Record Results and Analyst Upgrades

  • AI revenue hits 70% of sales, record quarter Teradyne's AI-related revenue now makes up nearly 70% of total sales, with first-quarter revenue of $1.28 billion up 87% year over year and EPS up 318%. This shows the company is selling much more test equipment as AI chips get more complex, directly boosting profits and the stock price.

    This is the core fundamental driver of the stock's rise, showing how AI demand translates into actual sales and earnings.

  • Analyst price targets raised to Street-high $550 Susquehanna, Cantor Fitzgerald, BofA, and Baird all raised their price targets, with Susquehanna setting a Street-high $550. These upgrades reflect stronger expectations for semiconductor equipment spending and a backlog extending beyond a year, which lifts investor confidence and can pull the stock higher.

    Analyst upgrades directly influence investor sentiment and can drive buying, making this a key near-term catalyst.

  • Robotics IPO sparks sector-wide interest Agility Robotics went public, causing sharp moves in robotics supply-chain stocks. Teradyne, which owns Universal Robots, saw its stock rise 140% year-to-date. This highlights Teradyne's robotics exposure as an additional growth driver beyond chip testing, attracting more investor attention.

    This event brings fresh attention to Teradyne's robotics segment, which is a secondary but growing part of its business.

  • Fair value raised on AI-driven forecasts Analysts increased Teradyne's fair value from $374.82 to $416.65, citing AI infrastructure spending and a semiconductor equipment backlog. They project long-term revenue growth of 22.9% and a profit margin of 29.9%, reinforcing the view that Teradyne is a long-term AI winner.

    This shows how professional investors are re-evaluating Teradyne's worth based on AI trends, which can justify higher stock prices.

Q2 2026
▲3

Teradyne rides AI test demand, defense deal, and index inclusion

  • Nasdaq-100 inclusion and Air Force contract Teradyne joined the Nasdaq-100 on June 22, which typically brings in passive fund buying and raises its profile. It also won a $139.9 million U.S. Air Force contract for diagnostic test kits, adding a new government revenue stream beyond chips and robotics.

    These are concrete new events that directly affect demand and capital flows for TER.

  • AI chip testing momentum Teradyne and Tokyo Electron launched an integrated test cell for AI chiplet packages, reinforcing Teradyne's role in advanced semiconductor testing. Its testing revenue jumped 87% year over year, with AI driving about 70% of that, showing strong underlying demand.

    This highlights the core growth driver—AI-related test demand—and a new product that supports future revenue.

  • Intel-Apple deal lifts semiconductor sentiment President Trump announced Apple will design and make chips with Intel in the U.S., boosting confidence in domestic chip production. Teradyne shares rose 5.4% as the deal signals more demand for test equipment from foundries.

    This event directly lifted TER's stock and points to a broader positive trend for semiconductor equipment suppliers.

  • Memory slowdown fears vs. Micron's blowout SK Hynix slowing HBM expansion triggered a sector sell-off, with Teradyne falling 8.3% as investors worried about near-term test demand. But Micron's strong earnings days later sent Teradyne up 10.5%, easing those fears and showing AI memory demand remains robust.

    This captures the main tug-of-war affecting TER's price this period—fear of a memory slowdown versus evidence of strong demand.

June 2026
▲3

Teradyne rides AI test demand, defense deal, and index inclusion

  • Nasdaq-100 inclusion and Air Force contract Teradyne joined the Nasdaq-100 on June 22, which typically brings in passive fund buying and raises its profile. It also won a $139.9 million U.S. Air Force contract for diagnostic test kits, adding a new government revenue stream beyond chips and robotics.

    These are concrete new events that directly affect demand and capital flows for TER.

  • AI chip testing momentum Teradyne and Tokyo Electron launched an integrated test cell for AI chiplet packages, reinforcing Teradyne's role in advanced semiconductor testing. Its testing revenue jumped 87% year over year, with AI driving about 70% of that, showing strong underlying demand.

    This highlights the core growth driver—AI-related test demand—and a new product that supports future revenue.

  • Intel-Apple deal lifts semiconductor sentiment President Trump announced Apple will design and make chips with Intel in the U.S., boosting confidence in domestic chip production. Teradyne shares rose 5.4% as the deal signals more demand for test equipment from foundries.

    This event directly lifted TER's stock and points to a broader positive trend for semiconductor equipment suppliers.

  • Memory slowdown fears vs. Micron's blowout SK Hynix slowing HBM expansion triggered a sector sell-off, with Teradyne falling 8.3% as investors worried about near-term test demand. But Micron's strong earnings days later sent Teradyne up 10.5%, easing those fears and showing AI memory demand remains robust.

    This captures the main tug-of-war affecting TER's price this period—fear of a memory slowdown versus evidence of strong demand.

▲3

Teradyne rides AI test demand, defense deal, and index inclusion

  • Nasdaq-100 inclusion and Air Force contract Teradyne joined the Nasdaq-100 on June 22, which typically brings in passive fund buying and raises its profile. It also won a $139.9 million U.S. Air Force contract for diagnostic test kits, adding a new government revenue stream beyond chips and robotics.

    These are concrete new events that directly affect demand and capital flows for TER.

  • AI chip testing momentum Teradyne and Tokyo Electron launched an integrated test cell for AI chiplet packages, reinforcing Teradyne's role in advanced semiconductor testing. Its testing revenue jumped 87% year over year, with AI driving about 70% of that, showing strong underlying demand.

    This highlights the core growth driver—AI-related test demand—and a new product that supports future revenue.

  • Intel-Apple deal lifts semiconductor sentiment President Trump announced Apple will design and make chips with Intel in the U.S., boosting confidence in domestic chip production. Teradyne shares rose 5.4% as the deal signals more demand for test equipment from foundries.

    This event directly lifted TER's stock and points to a broader positive trend for semiconductor equipment suppliers.

  • Memory slowdown fears vs. Micron's blowout SK Hynix slowing HBM expansion triggered a sector sell-off, with Teradyne falling 8.3% as investors worried about near-term test demand. But Micron's strong earnings days later sent Teradyne up 10.5%, easing those fears and showing AI memory demand remains robust.

    This captures the main tug-of-war affecting TER's price this period—fear of a memory slowdown versus evidence of strong demand.

© 2026 MarketIVWhy